Johnson Controls Joins The Climate Pledge

Johnson Controls (JCI) Wednesday said it has joined The Climate Pledge, a commitment co-founded by Amazon and Global Optimism aiming to reach net-zero carbon emissions by 2040. This is ten years ahead of the goal set out in the United Nations' Paris Climate Agreement.

The company said its signing aligns with its commitment to bring forward net-zero carbon emissions to 2040 from 2050.

As of now, 53 organizations from 18 industries across 12 countries have signed the Pledge. The Climate Pledge allows signatories to share access to technologies, best practices, and innovations in supply chain enhancements, and create joint action to address the most critical climate challenges.

In order to meet ambitious common environmental and sustainability goals, Johnson Controls will partner with many other companies.

George Oliver, Johnson Controls chairman and CEO, said, "Our recent announcement to achieve net-zero carbon emissions by 2040 through innovations and technologies such as our OpenBlue platform, further demonstrates our commitment to protect and preserve the environment."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT